| 10th week of 2019 patent applcation highlights part 8 |
| Patent application number | Title | Published |
|---|
| 20190070170 | METHOD OF SELECTIVELY INHIBITING MPGES-1 | 2019-03-07 |
| 20190070171 | ARIPIPRAZOLE INJECTABLE SUSPENSION FORMULATION HAVING PROLONGED SHELF LIFE | 2019-03-07 |
| 20190070172 | LYSINE-SPECIFIC HISTONE DEMETHYLASE AS A NOVEL THERAPEUTIC TARGET IN MYELOPROLIFERATIVE NEOPLASMS | 2019-03-07 |
| 20190070173 | COMBINATIONS FOR THE TREATMENT OF NEUROBLASTOMA | 2019-03-07 |
| 20190070174 | METHODS OF TREATING NEURODEGENERATIVE DISEASES | 2019-03-07 |
| 20190070175 | METHODS AND COMPOSITIONS FOR TREATING DIABETES, METABOLIC SYNDROME AND OTHER CONDITIONS | 2019-03-07 |
| 20190070176 | METHOD OF INCREASING BIOAVAILABILITY AND/OR PROLONGING OPHTHALMIC ACTION OF A DRUG | 2019-03-07 |
| 20190070177 | HISTONE DEACETYLASE 6 INHIBITION FOR ENHANCING T-CELL FUNCTION DURING ANTI-TUMOR RESPONSE AND TUMOR-PEPTIDE VACCINATION | 2019-03-07 |
| 20190070178 | METHODS FOR TREATING OR PREVENTING CARDIOVASCULAR DISORDERS AND LOWERING RISK OF CARDIOVASCULAR EVENTS | 2019-03-07 |
| 20190070179 | TLR7 AGONIST MALEATE SALT, CRYSTALLINE FORMS C, D AND E THEREOF, PREPARATION METHODS AND USES OF MALEATE SALT AND CRYSTALLINE FORMS | 2019-03-07 |
| 20190070180 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF A BETA-CATENIN-ASSOCIATED DISEASE OR DISORDER | 2019-03-07 |
| 20190070181 | FORMULATION OF TICAGRELOR OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | 2019-03-07 |
| 20190070182 | USES OF PYRIMIDO-PYRIDAZINONES TO TREAT CANCER | 2019-03-07 |
| 20190070183 | Targeting Casein Kinase-1 and PI3K/AKT/mTOR Pathways for Treatment of c-Myc-Overexpressing Cancers, Organ Transplant Associated Complications and Autoimmune Diseases | 2019-03-07 |
| 20190070184 | DEUTERATED PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATING CARDIOVASCULAR DISEASES | 2019-03-07 |
| 20190070185 | HSPC-SPARING TREATMENTS FOR RB-POSITIVE ABNORMAL CELLULAR PROLIFERATION | 2019-03-07 |
| 20190070186 | COMPOSITIONS AND METHODS FOR IMMUNE-MEDIATED CANCER THERAPY | 2019-03-07 |
| 20190070187 | 4-OXO-3,4-DIHYDRO-1,2,3-BENZOTRIAZINE MODULATORS OF GPR139 | 2019-03-07 |
| 20190070188 | PEDIATRIC DOSING FOR TREATMENT OF CANCER WITH AN EZH2 INHIBITOR | 2019-03-07 |
| 20190070189 | DIHYDROPYRIDOPHTHALAZINONE INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE (PARP) FOR USE IN TREATMENT OF DISEASES ASSOCIATED WITH A PTEN DEFICIENCY | 2019-03-07 |
| 20190070190 | INHIBITORS OF POLO-LIKE KINASE 4 (PLK4) FOR TREATING PEDIATRIC EMBRYONAL TUMORS | 2019-03-07 |
| 20190070191 | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CANCER USING PHENOTHIAZINE | 2019-03-07 |
| 20190070192 | PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM | 2019-03-07 |
| 20190070193 | COMPOUND FOR INHIBITION OF DELTA-5-DESATURASE (D5D) AND TREATMENT OF CANCER AND INFLAMMATION | 2019-03-07 |
| 20190070194 | PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF | 2019-03-07 |
| 20190070195 | PHARMACEUTICAL COMPOSITION | 2019-03-07 |
| 20190070196 | PHARMACEUTICAL DELIVERY SYSTEMS FOR HYDROPHOBIC DRUGS AND COMPOSITIONS COMPRISING SAME | 2019-03-07 |
| 20190070197 | TRANSDERMAL CREAM | 2019-03-07 |
| 20190070198 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF OPHTHALMIC CONDITIONS | 2019-03-07 |
| 20190070199 | HOMOGENEOUS OPHTHALMIC COMPOSITION | 2019-03-07 |
| 20190070200 | USE OF BILE ACIDS AND BILE SALTS AS ANTI BACTERIAL AGENTS FOR INHIBITION OF BACTERIAL CONJUGATION AND HORIZONTAL GENE TRANSFER | 2019-03-07 |
| 20190070201 | FIXED DOSE COMBINATION FOR PAIN RELIEF WITHOUT EDEMA | 2019-03-07 |
| 20190070202 | Fosfomycin Formulation for Parenteral Administration | 2019-03-07 |
| 20190070203 | ANTI-INFLAMMATORY PROPERTIES OF MARINE LIPID COMPOSITIONS | 2019-03-07 |
| 20190070204 | PROLIFERATIVE AGENT FOR FAECALIBACTERIUM | 2019-03-07 |
| 20190070205 | Compounds for Use in Wound Healing and Angiogenesis | 2019-03-07 |
| 20190070206 | Radiation - Sterilized Biodegradable Drug Delivery Compositions | 2019-03-07 |
| 20190070207 | ANTI-HEPATOMA-VIRUS AGENT | 2019-03-07 |
| 20190070208 | USE OF TRIACETYL-3-HYDROXYPHENYLADENOSINE IN PREPARING PHARMACEUTICALS FOR TREATMENT OF ATHEROSCLEROSIS | 2019-03-07 |
| 20190070209 | COMPOSITION AND METHODS FOR CONDITIONS ASSOCIATED WITH CHRONIC PULMONARY OBSTRUCTIVE DISEASE | 2019-03-07 |
| 20190070210 | COMPOSITION AND METHODS FOR CONDITIONS ASSOCIATED WITH CHRONIC PULMONARY OBSTRUCTIVE DISEASE | 2019-03-07 |
| 20190070211 | NIACINAMIDE (NAM) IN ISCHEMIC TISSUE INJURY | 2019-03-07 |
| 20190070212 | COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF INFECTIONS | 2019-03-07 |
| 20190070213 | ANTISENSE OLIGOMERS AND USES THEREOF | 2019-03-07 |
| 20190070214 | COMPOSITIONS AND METHODS OF THEIR USE | 2019-03-07 |
| 20190070215 | DEVICES AND METHODS FOR REDUCING THE APPEARANCE OF CELLULITE | 2019-03-07 |
| 20190070216 | Methods of Treating Osteoarthritis | 2019-03-07 |
| 20190070217 | CHOLESTYRAMINE GRANULES, ORAL CHOLESTYRAMINE FORMULATIONS AND USE THEREOF | 2019-03-07 |
| 20190070218 | METHOD FOR TREATING INFLAMMATORY BRAIN DISORDERS AND TRAUMATIC BRAIN INJURY | 2019-03-07 |
| 20190070219 | Homeopathic Nasal Gel, Swab, and Spray Formulations | 2019-03-07 |
| 20190070220 | ADOPTIVE T CELL THERAPY | 2019-03-07 |
| 20190070221 | Methods to Mobilize Tissue Resident Cells for Adoptive T Cell Therapy | 2019-03-07 |
| 20190070222 | PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY | 2019-03-07 |
| 20190070223 | Selection Method Of Highly Active Stem Cell For Treatment Of Intraventricular Hemorrhage In Preterm Infant | 2019-03-07 |
| 20190070224 | TISSUE REPAIR MATERIAL DERIVED FROM FISH SKIN AND MANUFACTURING METHOD THEREOF | 2019-03-07 |
| 20190070225 | MODULATION OF THE GUT MICROBIOME TO TREAT MENTAL DISORDERS OR DISEASES OF THE CENTRAL NERVOUS SYSTEM | 2019-03-07 |
| 20190070226 | PROBIOTIC THERAPIES FOR DEVELOPMENTAL DISORDERS AND OTHER NEUROLOGICAL DISORDERS | 2019-03-07 |
| 20190070227 | METHODS AND COMPOSITIONS RELATING TO MICROBIAL TREATMENT AND DIAGNOSIS OF DISORDERS | 2019-03-07 |
| 20190070228 | METHODS AND COMPOSITIONS RELATING TO MICROBIAL TREATMENT AND DIAGNOSIS OF DISORDERS | 2019-03-07 |
| 20190070229 | Composition comprising a lactic acid bacteria for preventing and treating vaginosis and the use thereof | 2019-03-07 |
| 20190070230 | LACTIC ACID BACTERIUM FOR PREPARING SILAGE AND ADDITIVE FOR PREPARING SILAGE | 2019-03-07 |
| 20190070231 | COMPOSITION COMPRISING BACTERIOPHAGES FOR REDUCING, ELIMINATING AND/OR PREVENTING SALMONELLA ENTERITIDIS, SALMONELLA TYPHIMURIUM AND SALMONELLA PARATYPHI B | 2019-03-07 |
| 20190070232 | METHODS OF CLONING PROPHAGES AND PRODUCING LYTIC PHAGE PARTICLES | 2019-03-07 |
| 20190070233 | METHODS OF TREATING SOLID OR LYMPHATIC TUMORS BY COMBINATION THERAPY | 2019-03-07 |
| 20190070234 | METHOD FOR FOODBORNE PATHOGEN REDUCTION IN POULTRY | 2019-03-07 |
| 20190070235 | METHOD FOR TREATING HEPATITIS B | 2019-03-07 |
| 20190070236 | TRADITIONAL CHINESE MEDICINE COMPOSITION AND USE THEREOF | 2019-03-07 |
| 20190070237 | TRADITIONAL CHINESE MEDICINE COMPOSITION AND USE THEREOF | 2019-03-07 |
| 20190070238 | SIMMONDSIN FORMULATION | 2019-03-07 |
| 20190070239 | HERBAL FORMULATION TO RAISE THE HUMAN BODY'S PH LEVEL FROM ONE THAT IS ACIDIC TO ONE THAT IS MORE ALKALINE | 2019-03-07 |
| 20190070240 | GYNOSTEMMA PENTAPHYLLUM-CONTAINING HEALTH CARE PHARMACEUTICAL COMPOSITION FOR PREVENTING HYPERLIPIDEMIA, HYPERTENSION, HYPERGLYCEMIA AND GOUT | 2019-03-07 |
| 20190070241 | COMPOSITION FOR RELIEVING MENOPAUSAL SYMPTOM OR OSTEOPOROSIS | 2019-03-07 |
| 20190070242 | NANOPARTICLE OPHTHALMIC COMPOSITION FOR THE TREATMENT OF OCULAR DISORDERS OR DISEASES | 2019-03-07 |
| 20190070243 | MUSCLE-ENHANCING AGENT | 2019-03-07 |
| 20190070244 | BOYSENBERRY COMPOSITIONS AND METHODS OF PREPARATION AND USE THEREOF | 2019-03-07 |
| 20190070245 | NUTRIPROTECTIVE DIET | 2019-03-07 |
| 20190070246 | TRADITIONAL CHINESE MEDICINE COMPOSITION AND USE THEREOF | 2019-03-07 |
| 20190070247 | Compositions and Methods for Treatment of Hereditary Cystatin C Amyloid Angiopathy (HCCAA) and Other Neurodegenerative Disorders Associated with Aberrant Amyloid Deposits | 2019-03-07 |
| 20190070248 | PEPTIDE MIMOTOPES OF THE CD3 T-CELL CO-RECEPTOR EPSILON CHAIN AND USES THEREOF | 2019-03-07 |
| 20190070249 | METHOD OF TREATMENT OR PROPHYLAXIS OF INFECTIONS OF THE EYE | 2019-03-07 |
| 20190070250 | ANGIOTENSIN II ALONE OR IN COMBINATION FOR THE TREATMENT OF HYPOTENSION | 2019-03-07 |
| 20190070251 | POLYMER CONJUGATES OF THERAPEUTIC PEPTIDES | 2019-03-07 |
| 20190070252 | CYCLOSPORIN COMPOSITIONS | 2019-03-07 |
| 20190070254 | SWEET TASTE RECEPTOR ANTAGONIST COMPOSITIONS | 2019-03-07 |
| 20190070255 | EPITOPE MIMICS | 2019-03-07 |
| 20190070256 | SYSTEMS AND METHODS FOR IMPROVED DELIVERY OF OSTEOINDUCTIVE MOLECULES IN BONE REPAIR | 2019-03-07 |
| 20190070257 | Methods for Prophylactically Preventing, Slowing the Progression of, or Treating Alzheimer's Disease | 2019-03-07 |
| 20190070258 | TARGETED OESOPHAGEAL ADMINISTRATION OF ZN-ALPHA2-GLYCOPROTEINS (ZAG), METHODS AND FORMULATIONS THEREOF | 2019-03-07 |
| 20190070259 | METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING CANCER | 2019-03-07 |
| 20190070260 | SUPPRESSION OF CELLULAR TRANSFORMATION AND DYSPLASIA BY TOPICAL APPLICATION OF LEFTY | 2019-03-07 |
| 20190070261 | MATERIALS AND METHODS FOR MODULATING GLUCOSE UPTAKE | 2019-03-07 |
| 20190070262 | INTERLEUKIN-18 VARIANTS AND METHODS OF USE | 2019-03-07 |
| 20190070263 | MODULATING GAMMA-C-CYTOKINE ACTIVITY | 2019-03-07 |
| 20190070264 | INTERLEUKIN 15 PROTEIN COMPLEX AND USE THEREOF | 2019-03-07 |
| 20190070265 | Pharmaceutical Composition for Use in the Treatment of a Neurodegenerative Disease | 2019-03-07 |
| 20190070266 | Liraglutide in Diabetic Foot Ulcer | 2019-03-07 |
| 20190070267 | DEVICE FOR DRUG RECONSTITUTION AND DELIVERY | 2019-03-07 |
| 20190070269 | LYSIN POLYPEPTIDES ACTIVE AGAINST GRAM-NEGATIVE BACTERIA | 2019-03-07 |
| 20190070270 | Thrombin Microcapsules, Preparation and Uses Thereof | 2019-03-07 |
| 20190070271 | FACTOR IX GENE THERAPY | 2019-03-07 |
